Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Arcellx, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 186 | 2 | 211 | +27 |
| Shares | 49.5M | 127.3K | 59.2M | +9.81M (+19.9%) |
| Value | $4.13B | $13.0M | $4.54B | +$416.0M (+10.1%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Arcellx, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (25)
Institutions that held Arcellx, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Suvretta Capital Management, LLC | 689,950 | $57.6M |
| Adage Capital Partners GP, L.L.C. | 292,009 | $24.4M |
| Great Point Partners LLC | 100,000 | $8.35M |
| Cutter Capital Management, LP | 89,863 | $7.50M |
| StemPoint Capital LP | 60,076 | $5.02M |
| Jane Street Group, LLC | 54,918 | $4.59M |
| Standard Life Aberdeen plc | 50,796 | $4.24M |
| Alps Advisors Inc | 40,988 | $3.42M |
| Caption Management, LLC | 37,580 | $3.14M |
| SG Americas Securities, LLC | 12,035 | $1.00M |
| MYDA Advisors LLC | 10,000 | $835.1K |
| D. E. Shaw & Co., Inc. | 6,305 | $526.5K |
| GTS Securities LLC | 4,739 | $395.8K |
| Tudor Investment Corp Et Al | 4,409 | $368.2K |
| Group One Trading, L.P. | 3,709 | $309.7K |
| Glenmede Trust Co NA | 3,615 | $301.9K |
| Entropy Technologies, LP | 3,509 | $293.0K |
| Nomura Holdings Inc | 3,197 | $267.0K |
| Acadian Asset Management LLC | 2,953 | $246.0K |
| EntryPoint Capital, LLC | 2,501 | $208.9K |
| Torno Capital, LLC | 2,000 | $167.0K |
| Quest Partners LLC | 1,532 | $127.9K |
| Quarry LP | 1,500 | $125.3K |
| Catalyst Funds Management Pty Ltd | 400 | $33.4K |
| Global Retirement Partners, LLC | 12 | $1.00K |
Not filed for Q4 2024 yet (2)
Institutions that held Arcellx, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Eagle Asset Management Inc | 122,329 | $12.6M |
| Raymond James & Associates | 4,992 | $416.9K |